BioCentury | Sep 7, 2015
Company News

Celsis, Charles River deal

...its acquisition of supply/service company Celsis for $212 million in cash (see BioCentury, July 20). Celsis International Ltd....
BioCentury | Jul 20, 2015
Company News

Celsis, Charles River deal

...Charles River will acquire supply/service company Celsis for $212 million in cash. Celsis provides life science...
...River reported $1.3 billion in 2014 revenue, and Celsis did not respond to revenue inquiries. Celsis International Ltd....
BioCentury | Feb 4, 2013
Finance

Wale(s) of experience

...head of the U.K. life sciences team at PricewaterhouseCoopers; and David Baynes, a co-founder of Celsis...
BioCentury | Jan 9, 2012
Company News

AAIPharma Services, Celsis deal

...AAIPharma acquired Celsis' Celsis Analytical Services division, which performs material testing services. AAIPharma said the acquisition...
...its capabilities in material testing services. Details were not disclosed. AAIPharma Services , Wilmington, N.C. Celsis...
BioCentury | Oct 19, 2009
Company News

Celsis, J O Hambro Capital Management Group deal

...supply/service company Celsis for 232.5p per share in cash, or about £54.5 million ($85.8 million). Celsis...
...CEO Jay LeCoque and CFO Christian Madrolle will retain their positions (see BioCentury, Aug. 10). Celsis...
BioCentury | Aug 10, 2009
Company News

Celsis deal

...Investment bank North Atlantic Value LLP will acquire supply/service company Celsis for 232.5p per share in...
...in cash, or about £54.5 million ($91.3 million). The price is a 14% premium to Celsis'...
...million and a 12-month operating profit of $13.2 million. Nomura Code Securities Ltd. advised Celsis. Celsis...
BioCentury | Feb 16, 2009
Company News

Celsis, Promega sales and marketing update

...its bioluminescent ADME-Tox assays with cryopreserved plateable hepatocytes from Celsis' Celsis In Vitro Technologies division. Celsis...
...use with Promega's specific P450-Glo CYP Assays to study cytochrome P450 gene induction and inhibition. Celsis...
...lots of hepatocytes for use with Promega's GSH-Glo Glutathione Assay for investigating mechanisms of hepatotoxicity. Celsis...
BioCentury | Oct 15, 2007
Company News

Celsis management update

...U.K. Business: Diagnostic, Supply/Service, ADMET Hired: Philip Vorwald as VP and general manager of CEL's Celsis...
BioCentury | May 21, 2007
Company News

Celsis board of directors update

Celsis International plc (LSE:CEL), Newmarket, U.K. Business: Diagnostic Appointed: Peter Jensen, former president of worldwide supply chain operations at GlaxoSmithKline plc , as non-executive director; and Nicholas Badman, CFO of Evolutec plc, as non-executive director WIR...
BioCentury | Aug 14, 2006
Company News

Celsis, In Vitro Technologies Inc. deal

...see BioCentury, June 19). In Vitro offers in vitro ADMET tools and services to companies. Celsis...
Items per page:
1 - 10 of 61
BioCentury | Sep 7, 2015
Company News

Celsis, Charles River deal

...its acquisition of supply/service company Celsis for $212 million in cash (see BioCentury, July 20). Celsis International Ltd....
BioCentury | Jul 20, 2015
Company News

Celsis, Charles River deal

...Charles River will acquire supply/service company Celsis for $212 million in cash. Celsis provides life science...
...River reported $1.3 billion in 2014 revenue, and Celsis did not respond to revenue inquiries. Celsis International Ltd....
BioCentury | Feb 4, 2013
Finance

Wale(s) of experience

...head of the U.K. life sciences team at PricewaterhouseCoopers; and David Baynes, a co-founder of Celsis...
BioCentury | Jan 9, 2012
Company News

AAIPharma Services, Celsis deal

...AAIPharma acquired Celsis' Celsis Analytical Services division, which performs material testing services. AAIPharma said the acquisition...
...its capabilities in material testing services. Details were not disclosed. AAIPharma Services , Wilmington, N.C. Celsis...
BioCentury | Oct 19, 2009
Company News

Celsis, J O Hambro Capital Management Group deal

...supply/service company Celsis for 232.5p per share in cash, or about £54.5 million ($85.8 million). Celsis...
...CEO Jay LeCoque and CFO Christian Madrolle will retain their positions (see BioCentury, Aug. 10). Celsis...
BioCentury | Aug 10, 2009
Company News

Celsis deal

...Investment bank North Atlantic Value LLP will acquire supply/service company Celsis for 232.5p per share in...
...in cash, or about £54.5 million ($91.3 million). The price is a 14% premium to Celsis'...
...million and a 12-month operating profit of $13.2 million. Nomura Code Securities Ltd. advised Celsis. Celsis...
BioCentury | Feb 16, 2009
Company News

Celsis, Promega sales and marketing update

...its bioluminescent ADME-Tox assays with cryopreserved plateable hepatocytes from Celsis' Celsis In Vitro Technologies division. Celsis...
...use with Promega's specific P450-Glo CYP Assays to study cytochrome P450 gene induction and inhibition. Celsis...
...lots of hepatocytes for use with Promega's GSH-Glo Glutathione Assay for investigating mechanisms of hepatotoxicity. Celsis...
BioCentury | Oct 15, 2007
Company News

Celsis management update

...U.K. Business: Diagnostic, Supply/Service, ADMET Hired: Philip Vorwald as VP and general manager of CEL's Celsis...
BioCentury | May 21, 2007
Company News

Celsis board of directors update

Celsis International plc (LSE:CEL), Newmarket, U.K. Business: Diagnostic Appointed: Peter Jensen, former president of worldwide supply chain operations at GlaxoSmithKline plc , as non-executive director; and Nicholas Badman, CFO of Evolutec plc, as non-executive director WIR...
BioCentury | Aug 14, 2006
Company News

Celsis, In Vitro Technologies Inc. deal

...see BioCentury, June 19). In Vitro offers in vitro ADMET tools and services to companies. Celsis...
Items per page:
1 - 10 of 61